Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. März 2024 12:19 ET | Quelle: AcedrA BioPharmaceuticals; TaiMed Biologics

TaiMed Biologics and AcedrA BioPharmaceuticals Partner to Commercialize Trogarzo® (Ibalizumab-uiyk) in the Middle East and North Africa Region

TaiMed and AcedrA officially signed an exclusive license, commercialization, and distribution agreement for Trogarzo in the MENA region.
17. Juni 2021 08:17 ET | Quelle: InvestorBrandNetwork (IBN)

InvestorBrandNetwork (IBN) Announces Latest Episode of Stock2Me Podcast featuring Tryp Therapeutics Inc. Chairman and CEO Greg McKee

LOS ANGELES, June 17, 2021 (GLOBE NEWSWIRE) -- (via InvestorWire) InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
18. Mai 2021 16:05 ET | Quelle: Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals to Participate in Upcoming Investor Conferences

HANOVER, MD., May 18, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve...
14. Januar 2021 04:30 ET | Quelle: Juva Life Inc.

Juva Life Unifies and Accelerates Brand Marketing Plans

VANCOUVER, British Columbia, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTC: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a premier California based...